ADMA BIOLOGICS, INC. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a7730ab1-6664-4644-91c8-35de8305f855/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $510.2M | 2025-01-01 – 2025-12-31 | evidence 0001140361-26-006815 |
| FY 2024 | $426.5M | 2024-01-01 – 2024-12-31 | evidence 0001140361-25-009257 |
| FY 2023 | $258.2M | 2023-01-01 – 2023-12-31 | evidence 0001140361-24-010147 |
| FY 2022 | $154.1M | 2022-01-01 – 2022-12-31 | evidence 0001140361-24-010147 |
| FY 2021 | $80.9M | 2021-01-01 – 2021-12-31 | evidence 0001140361-24-010147 |
| FY 2020 | $42.2M | 2020-01-01 – 2020-12-31 | evidence 0001140361-22-011030 |
| FY 2019 | $29.3M | 2019-01-01 – 2019-12-31 | evidence 0001193805-20-000348 |
| FY 2018 | $17.0M | 2018-01-01 – 2018-12-31 | evidence 0001193805-19-000281 |
| FY 2017 | $22.8M | 2017-01-01 – 2017-12-31 | evidence 0001193805-19-000281 |
| FY 2016 | $10.5M | 2016-01-01 – 2016-12-31 | evidence 0001193805-17-000330 |
| FY 2015 | $7.1M | 2015-01-01 – 2015-12-31 | evidence 0001193805-16-002889 |
| FY 2014 | $5.8M | 2014-01-01 – 2014-12-31 | evidence 0001193805-15-000352 |
| FY 2013 | $3.0M | 2013-01-01 – 2013-12-31 | evidence 0001193805-14-000641 |
| FY 2012 | $1.1M | 2012-01-01 – 2012-12-31 | evidence 0001193805-14-000641 |
| FY 2011 | $761.0k | 2011-01-01 – 2011-12-31 | evidence 0001193805-13-000585 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ADMA BIOLOGICS, INC. — all facts · Net Income · Operating Income